OA03.05 Tocilizumab for the Management of Immune Mediated Adverse Events Secondary to PD-1 Blockade: Overall Survival Analysis Topic: Medical Oncology

Academic Article

Published In

Digital Object Identifier (doi)

Author List

  • Stroud CRG; Hegde A; Naqash AR; Cherry C; Parent T; Hardin J; Walker PR
  • Start Page

  • s1554
  • End Page

  • s1555
  • Volume

  • 12
  • Issue

  • 11